Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-04-29 | Mr. Reardon received both his undergraduate degree in East Asian history and his M.B.A. from Harvard University. |
| 2009-04-30 | Mr. Reardon was a business assurance (audit) partner at PricewaterhouseCoopers LLP and leader of its life sciences industry practice. |
| 2010-04-30 | Mr. Reardon received both his undergraduate degree in East Asian history and his M.B.A. from Harvard University. Our Board of Directors has concluded that Mr. Reardon should serve as a director as of the date of this proxy statement because of his extensive expertise in accounting and financial matters and his experience in analyzing and evaluating financial statements as a former auditor, in particular in the biopharmaceutical industry. |
| 2011-04-29 | Mr. Reardon was a business assurance (audit) partner at PricewaterhouseCoopers LLP and leader of its life sciences industry practice. |
| 2012-04-27 | Mr. Reardon was a business assurance (audit) partner at PricewaterhouseCoopers LLP and has expertise in accounting and financial matters. |
| 2013-04-29 | Mr. Reardon received both his undergraduate degree in East Asian history and his M.B.A. from Harvard University. Our Board of Directors has concluded that Mr. Reardon should serve as a director as of the date of this proxy statement because of his extensive expertise in accounting and financial matters and his experience in analyzing and evaluating financial statements as a former auditor, in particular in the biopharmaceutical industry. |
| 2014-04-30 | Until his retirement in 2002 from PricewaterhouseCoopers LLP, an international accounting firm, where he was employed from June 1973 to July 2002, Mr. Reardon was a business assurance (audit) partner at the firm's Boston office and leader of its life sciences industry practice for New England and the eastern United States. |
| 2015-04-30 | Mr. Reardon received both his undergraduate degree in East Asian history and his M.B.A. from Harvard University. Our Board of Directors has concluded that Mr. Reardon should serve as a director as of the date of this proxy statement because of his extensive expertise in accounting and financial matters and his experience in analyzing and evaluating financial statements as a former auditor, in particular in the biopharmaceutical industry. |
Data sourced from SEC filings. Last updated: 2026-02-03